| scholarly article | Q13442814 |
| P50 | author | Andreas Hiergeist | Q85649630 |
| Eric G. Pamer | Q88250963 | ||
| Marcel R.M. van den Brink | Q17198821 | ||
| Jonathan U Peled | Q59699836 | ||
| P2093 | author name string | Wolfgang Herr | |
| Peter J Oefner | |||
| Markus Weber | |||
| Ernst Holler | |||
| Robert R Jenq | |||
| André Gessner | |||
| Daniela Weber | |||
| Katja Dettmer | |||
| Ying Taur | |||
| Daniel Wolff | |||
| Joachim Hahn | |||
| Josef Koestler | |||
| P2860 | cites work | Competing risk analysis using R: an easy guide for clinicians | Q80466908 |
| Graft-versus-host disease | Q83468020 | ||
| Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation | Q24626051 | ||
| Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities | Q24647611 | ||
| A core gut microbiome in obese and lean twins | Q24649648 | ||
| Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB | Q29547254 | ||
| Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy | Q29547619 | ||
| The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing | Q29615054 | ||
| Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells | Q29618126 | ||
| Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota | Q29618128 | ||
| The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide | Q31144277 | ||
| Why should we need the gut microbiota to respond to cancer therapies? | Q33553530 | ||
| The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. | Q34047880 | ||
| Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies | Q34109852 | ||
| Characterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia | Q34129359 | ||
| Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america | Q34160380 | ||
| European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia | Q34390823 | ||
| Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits | Q34596030 | ||
| A case for antibiotic perturbation of the microbiota leading to allergy development | Q35028137 | ||
| The microbiome and regulation of mucosal immunity | Q35065019 | ||
| Intestinal microbiota-related effects on graft-versus-host disease. | Q35587907 | ||
| Decreased secretion of Paneth cell α-defensins in graft-versus-host disease | Q35704063 | ||
| Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. | Q35713301 | ||
| Review article: the antimicrobial effects of rifaximin on the gut microbiota | Q35855732 | ||
| Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease | Q35892249 | ||
| Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. | Q37152028 | ||
| Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice | Q37191056 | ||
| Early life exposure to antibiotics and the risk of childhood allergic diseases: an update from the perspective of the hygiene hypothesis | Q38113366 | ||
| Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time | Q38472178 | ||
| Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation | Q39901709 | ||
| Comparative in vitro activities of SMT19969, a new antimicrobial agent, against 162 strains from 35 less frequently recovered intestinal Clostridium species: implications for Clostridium difficile recurrence | Q41907574 | ||
| Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors | Q43546471 | ||
| P433 | issue | 5 | |
| P921 | main subject | antibiotic | Q12187 |
| risk factor | Q1475848 | ||
| P304 | page(s) | 845-852 | |
| P577 | publication date | 2017-02-14 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation | |
| P478 | volume | 23 |
| Q90666975 | A gut microbiota score predicting acute graft-versus-host disease following myeloablative allogeneic hematopoietic stem cell transplantation |
| Q49817055 | Advances in intestinal microbiota and graft versus host disease |
| Q38743931 | Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis |
| Q54205996 | Antibiotic Exposure Prior to Respiratory Viral Infection is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients. |
| Q58050151 | Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centers |
| Q91254526 | Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation |
| Q90147754 | Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation |
| Q95840249 | Ciprofloxacin prophylaxis is associated with a lower incidence of gram-negative bacteremia in patients undergoing allogeneic hematopoietic cell transplantation |
| Q90036104 | Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population |
| Q90166047 | Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study |
| Q64115348 | Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia |
| Q91260567 | Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells |
| Q89777592 | Empiric antibiotic use in allogeneic hematopoietic cell transplantation: should we avoid anaerobe coverage? |
| Q64232722 | Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society |
| Q59333340 | GVHD: biology matters |
| Q90029154 | GVHD: biology matters |
| Q92556893 | Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives |
| Q49958101 | Gut microbiota injury in allogeneic haematopoietic stem cell transplantation |
| Q88938171 | Hematopoiesis and the bacterial microbiome |
| Q89108835 | High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients |
| Q88593565 | Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation |
| Q91693301 | Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy |
| Q47742900 | Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation |
| Q49827641 | Infectious diseases - a specialty of internal medicine |
| Q55398415 | Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease via the Treg/Th17 Balance in Allo-HSCT Recipients. |
| Q58756414 | Microbial metabolite sensor GPR43 controls severity of experimental GVHD |
| Q90319016 | Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease |
| Q89893103 | Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation |
| Q93377243 | Pre-transplant recovery of microbiome diversity without recovery of the original microbiome |
| Q58050171 | Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease |
| Q58050148 | Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples |
| Q91783476 | Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant |
| Q47566513 | Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation |
| Q90098536 | Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation |
| Q98465508 | The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant |
| Q57028383 | The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials |
| Q52689883 | The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. |
| Q41987235 | The Stool Microbiota at Neutrophil Recovery is Predictive for Severe Acute Graft versus Host Disease after Hematopoietic Cell Transplantation |
| Q91664568 | The gut microbiota and graft-versus-host disease |
| Q40153463 | The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection |
| Q56379522 | Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity |
Search more.